L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma ModelPaola Orecchia, Barbara Carnemolla, Enrica Balza et al.|Cancers|2019Cited by 24
PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolismOmbretta Garbarino, Cinzia Domenicotti, Gabriella Pietra et al.|Frontiers in Oncology|2023Cited by 11